Insulin secretion and sensitivity in healthy adults with low vitamin D are not affected by high-dose ergocalciferol administration: a randomized controlled trial.

Deborah M MitchellBenjamin Z LederEnrico CaglieroNatalia MendozaMaria P HenaoDouglas L HaydenJoel S FinkelsteinSherri-Ann M Burnett-Bowie

Published in: The American journal of clinical nutrition (2015)

In healthy persons with low 25(OH)D(total), ergocalciferol administration for 12 wk normalizes 25(OH)D(total) but does not improve insulin secretion, insulin sensitivity, or other markers of metabolic health.

Keyphrases

high dose
healthcare
public health
low dose
mental health
stem cell transplantation
risk assessment
climate change
human health